GKDCOJNJPZHEET-SBUREZEXSA-N
C28H26ClF3N8O4S2 — CID 155380513
Data last refreshed: (MolForge compound catalog, from PubChem)
About GKDCOJNJPZHEET-SBUREZEXSA-N
GKDCOJNJPZHEET-SBUREZEXSA-N (PubChem CID 155380513) has the molecular formula C28H26ClF3N8O4S2 and a molecular weight of 695.15 g/mol. Its IUPAC name is N-[(3R,6S)-3-(2-chloro-4-fluorophenyl)-4-[1-(difluoromethyl)pyrazol-3-yl]-1-(1,3-thiazol-2-yl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-6-yl]-4-hydroxy-4-(1,3-oxazol-2-yl)piperidine-1-sulfonamide.
Molecular Properties
| Compound Name | GKDCOJNJPZHEET-SBUREZEXSA-N |
|---|---|
| PubChem CID | 155380513 |
| Molecular Formula | C28H26ClF3N8O4S2 |
| Molecular Weight | 695.15 g/mol |
| Exact Mass | 694.12 |
| IUPAC Name | N-[(3R,6S)-3-(2-chloro-4-fluorophenyl)-4-[1-(difluoromethyl)pyrazol-3-yl]-1-(1,3-thiazol-2-yl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-6-yl]-4-hydroxy-4-(1,3-oxazol-2-yl)piperidine-1-sulfonamide |
| SMILES | O=S(=O)(N[C@H]1CC2=C(c3ccn(C(F)F)n3)[C@H](c3ccc(F)cc3Cl)N=C(c3nccs3)N2C1)N1CCC(O)(c2ncco2)CC1 |
| InChI | InChI=1S/C28H26ClF3N8O4S2/c29-19-13-16(30)1-2-18(19)23-22(20-3-8-40(36-20)27(31)32)21-14-17(15-39(21)24(35-23)25-33-7-12-45-25)37-46(42,43)38-9-4-28(41,5-10-38)26-34-6-11-44-26/h1-3,6-8,11-13,17,23,27,37,41H,4-5,9-10,14-15H2/t17-,23-/m0/s1 |
| InChIKey | GKDCOJNJPZHEET-SBUREZEXSA-N |
| XLogP | 4.32 |
| TPSA | 141.98 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 695.15 |
| LogP ≤ 5 | 4.32 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155380513 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.